Serotonin syndrome masquerading as disease flare in lupus nephritis with end-stage renal disease

被引:6
|
作者
Navarroza, Rodeo, V [1 ]
Zamora, Leonid D. [1 ]
Navarra, Sandra, V [1 ]
机构
[1] Univ Santo Tomas Hosp, Sect Rheumatol, Manila, Philippines
关键词
end-stage renal disease; linezolid; lupus nephritis; serotonin syndrome; serotonin toxicity; TRAMADOL; TOXICITY;
D O I
10.1111/1756-185X.13683
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction Serotonin syndrome is a potentially life-threatening condition characterized by the triad of mental status changes, autonomic instability, and neuromuscular changes. We report a case of serotonin syndrome masquerading as disease flare in a lupus nephritis patient with end-stage renal disease receiving linezolid for the treatment of infected pseudoaneurysm. Case report A 36-year-old female lupus nephritis patient on maintenance hemodialysis for end-stage renal disease had been on multiple antibiotics, including anti-tuberculosis medications, over the past month for infected pseudoaneurysm complicating her arteriovenous fistula. Due to minimal response, she underwent pseudoaneurysmal ligation and given linezolid. Two days later, she developed chest pain, tachycardia, hypertension, tremors, later accompanied by high-grade fever, diarrhea, insomnia, and body weakness. Although fully awake and oriented, she was markedly agitated, mildly icteric, had hyperreflexia and asthenia with proximal muscle strength graded 3/5 in all extremities. Blood counts revealed anemia and thrombocytopenia; ancillary tests showed aspartate aminotransferase markedly higher than alanine aminotransferase, elevated serum lactate dehydrogenase and creatine kinase, and low C3 levels. Intravenous hydrocortisone was started for a suspected lupus flare. On the background of linezolid, isoniazid, and tramadol administration, serotonin syndrome with rhabdomyolysis was strongly considered. Offending drugs were discontinued, resulting in the dramatic improvement of symptoms and improved strength and well-being. The steroid was successfully tapered to 5 mg/day and a week later, she remained afebrile without recurrence of symptoms. Conclusion Serotonin syndrome should be considered in patients on multiple serotonergic agents on the background of end-stage renal disease. Prompt recognition and distinction from lupus activity can significantly impact management decisions.
引用
收藏
页码:1933 / 1936
页数:4
相关论文
共 50 条
  • [1] Predictors of End-Stage Renal Disease in Lupus Nephritis
    Tselios, Kostantinos
    Gladman, Dafna
    Su, Jiandong
    Urowitz, Murray
    [J]. JOURNAL OF RHEUMATOLOGY, 2019, 46 (07) : 813 - 813
  • [2] Predictors of End-Stage Renal Disease in Lupus Nephritis
    Deeb, Mery
    Tselios, Konstantinos
    Gladman, Dafna D.
    Su, Jiandong
    Urowitz, Murray
    [J]. ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [3] Lupus Nephritis and End-stage Kidney Disease
    Maroz, Natallia
    Segal, Mark S.
    [J]. AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2013, 346 (04): : 319 - 323
  • [4] Familial clustering of end-stage renal disease in blacks with lupus nephritis
    Freedman, BI
    Wilson, CH
    Spray, BJ
    Tuttle, AB
    Olorenshaw, IM
    Kammer, GM
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1997, 29 (05) : 729 - 732
  • [5] SURVIVAL PATTERNS IN LUPUS NEPHRITIS WITH END-STAGE RENAL-DISEASE
    WADHWA, NK
    KANT, KS
    CLYNE, DH
    FIRST, MR
    POLLAK, VE
    [J]. KIDNEY INTERNATIONAL, 1988, 33 (01) : 212 - 212
  • [6] DISEASE FLARE OF SYSTEMIC LUPUS ERYTHEMATOSUS IN PATIENTS WITH END-STAGE RENAL DISEASE ON DIALYSIS
    Kim, Y. E.
    Choi, S. J.
    Lim, D. H.
    Ahn, S. M.
    Oh, J. S.
    Kim, Y. G.
    Lee, C. K.
    Yoo, B.
    Hong, S.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1355 - 1355
  • [7] Evaluation of renal grafts in patients with lupus nephritis as cause of end-stage renal disease
    Verdejo, PV
    Rivera, CF
    Hernández, AA
    Naveiro, RG
    Vilariño, MC
    Fernández, CT
    Cañedo, FV
    [J]. TRANSPLANTATION PROCEEDINGS, 2005, 37 (03) : 1426 - 1427
  • [8] Renal transplantation for end-stage renal disease caused by systemic lupus erythematosus nephritis
    Clark, WF
    Jevnikar, AM
    [J]. SEMINARS IN NEPHROLOGY, 1999, 19 (01) : 77 - 85
  • [9] The effects of cyclophosphamide and mycophenolate on end-stage renal disease and death of lupus nephritis
    Koo, H. S.
    Kim, Y. C.
    Lee, S. W.
    Kim, D. K.
    Oh, K-H
    Joo, K. W.
    Kim, Y. S.
    Ahn, C.
    Han, J. S.
    Kim, S.
    Chin, H. J.
    [J]. LUPUS, 2011, 20 (13) : 1442 - 1449
  • [10] Methodological quality of studies of end-stage renal disease risks in lupus nephritis
    Maria Tektonidou
    Abhijit Dasgupta
    Michael Ward
    [J]. Arthritis Research & Therapy, 16